Bruker Corporation
Bruker Corporation Fundamental Analysis
Bruker Corporation (BRKR) shows moderate financial fundamentals with a PE ratio of -649.45, profit margin of -0.25%, and ROE of -0.40%. The company generates $3.4B in annual revenue with strong year-over-year growth of 13.56%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 33.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BRKR's fundamental strength across five key dimensions:
Efficiency Score
WeakBRKR struggles to generate sufficient returns from assets.
Valuation Score
ModerateBRKR shows balanced valuation metrics.
Growth Score
ModerateBRKR shows steady but slowing expansion.
Financial Health Score
ExcellentBRKR maintains a strong and stable balance sheet.
Profitability Score
WeakBRKR struggles to sustain strong margins.
Key Financial Metrics
Is BRKR Expensive or Cheap?
P/E Ratio
BRKR trades at -649.45 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BRKR's PEG of 5.31 indicates potential overvaluation.
Price to Book
The market values Bruker Corporation at 2.27 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.95 times EBITDA. This signals the market has high growth expectations.
How Well Does BRKR Make Money?
Net Profit Margin
For every $100 in sales, Bruker Corporation keeps $-0.25 as profit after all expenses.
Operating Margin
Core operations generate 5.44 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-0.40 in profit for every $100 of shareholder equity.
ROA
Bruker Corporation generates $-0.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bruker Corporation generates limited operating cash flow of $134.29M, signaling weaker underlying cash strength.
Free Cash Flow
Bruker Corporation generates weak or negative free cash flow of $43.36M, restricting financial flexibility.
FCF Per Share
Each share generates $0.28 in free cash annually.
FCF Yield
BRKR converts 0.78% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-649.45
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.31
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.27
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.63
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.83
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.73
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.00
vs 25 benchmark
ROA
Return on assets percentage
-0.00
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How BRKR Stacks Against Its Sector Peers
| Metric | BRKR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -649.45 | 28.81 | Better (Cheaper) |
| ROE | -0.40% | 643.00% | Weak |
| Net Margin | -0.25% | -44312.00% (disorted) | Weak |
| Debt/Equity | 0.83 | 0.36 | Weak (High Leverage) |
| Current Ratio | 1.73 | 4.50 | Neutral |
| ROA | -0.14% | -17799.00% (disorted) | Weak |
BRKR outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bruker Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
69.18%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-40.26%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
22.66%
Industry Style: Defensive, Growth, Innovation
High Growth